Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 747-752

  Cella, Marina ^a   Scheidegger, Doris ^a   Palmer Lehmann, Kathrin ^b   Lane, Peter ^a   Lanzavecchia, Antonio ^a   Alber, Gottfried ^b  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; DENDRITIC CELL; ENZYME ACTIVATION; HELPER CELL; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029812593     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.747     Document Type: Article

References (25)

1. Hsieh, C.S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
2. Manetti, R., P. Parronchi, M.G. Guidizi, M.P. Piccinini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural Killer cell stimulatory factor (interleukin 12 [IL12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL4-producing Th cells. J. Exp. Med. 177:1199-1204.
3. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today. 14:335-338.
4. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
5. Inaba, K., J.P. Metlay, M.T. Crowley, M. Witmer-Pack, and R.M. Steinman. 1990. Dendritic cells as antigen presenting cells in vivo. Int. Rev. Immunol. 6:197-206.
6. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba, and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature epidermal Langerhans cells. J. Exp. Med. 169: 1169-1178.
7. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major hystocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
8. Roake, J.A., A.S. Rao, P.J. Morris, C.P. Larsen, D.F. Hankins, and J.M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
9. Macatonia, S.E., N.A. Hosken, M. Litton, P. Vieira, C.S. Hsieh, J.A. Culpepper, M. Wysocka, G. Trinchieri, K.M. Murphy, and A. O'Garra. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154: 5071-5079.
10. Scheicher, C., M. Mehlig, H.P. Dienes, and K. Reske. 1995. Uptake of microparticle-absorbed protein antigen by bone marrow dendritic cells results in upregulation of interleukin-1α and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur. J. Immunol. 25:1566-1572.
11. Traunecker, A., F. Oliveri, and K. Karjalainen. 1991. Myeloma-based expression system for production of large mammalian proteins. Trends Biotechnol. 9:109-112.
12. Lane, P., C. Burdet, F. Mc Connell, A. Lanzavecchia, and E. Padovan. 1995. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788-1793.
13. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature (Lond.). 314:537-539.
14. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-α. J. Exp. Med. 179:1109-1118.
15. Freudenthal, P.S., and R.M. Steinman. 1990. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA. 87: 7698-7702.
16. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181:577-584.
17. Gately, M.K., R. Chizzonite, and D.H. Presky. 1995. Measurement of human and mouse interleukin-12. Curr. Prot. Immunol. 3:15.6.16.1-6.16.15.
18. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of Interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181: 537-546.
19. Murphy, E.E., G. Terres, S.E. Macatonia, C.S. Hsieh, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223-231.
20. Shu, U., M. Kiniwa, C.Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125-1128.
21. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
22. Burk, M.R., L. Mori, and G. De Libero. 1995. Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25:2052-2058.
23. -subset. J. Exp. Med. 177:1763-1771.
24. Gately, M.K., R.R. Warrier, S. Honasoge, D.M. Carvajal, D.A. Faherty, S.E. Connaughton, T.D. Anderson, U. Sarmiento, B.R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolitic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6:157-167.
25. Lanzavecchia, A. 1993. Identifying strategies for immune intervention. Science (Wash. DC). 260:937-944.